Your browser doesn't support javascript.
loading
Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model.
Vézina, Amélie; Manglani, Monica; Morris, DreeAnna; Foster, Brandon; McCord, Matthew; Song, Hua; Zhang, Meili; Davis, Dionne; Zhang, Wei; Bills, Jessica; Nagashima, Kunio; Shankarappa, Priya; Kindrick, Jessica; Walbridge, Stuart; Peer, Cody J; Figg, William D; Gilbert, Mark R; McGavern, Dorian B; Muldoon, Leslie L; Jackson, Sadhana.
Afiliação
  • Vézina A; Neuro-Oncology Branch, NCI, NIH, Bethesda, Maryland.
  • Manglani M; Electron Microscope Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Morris D; Viral Immunology and Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland.
  • Foster B; Department of Neurology, Oregon Health & Sciences University, Portland, Oregon.
  • McCord M; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland.
  • Song H; Neuro-Oncology Branch, NCI, NIH, Bethesda, Maryland.
  • Zhang M; Neuro-Oncology Branch, NCI, NIH, Bethesda, Maryland.
  • Davis D; Neuro-Oncology Branch, NCI, NIH, Bethesda, Maryland.
  • Zhang W; Neuro-Oncology Branch, NCI, NIH, Bethesda, Maryland.
  • Bills J; Neuro-Oncology Branch, NCI, NIH, Bethesda, Maryland.
  • Nagashima K; Department of Neurology, Oregon Health & Sciences University, Portland, Oregon.
  • Shankarappa P; Electron Microscope Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Kindrick J; Genitourinary Malignancies Branch, Molecular Pharmacology Section, NCI, NIH, Bethesda, Maryland.
  • Walbridge S; Genitourinary Malignancies Branch, Molecular Pharmacology Section, NCI, NIH, Bethesda, Maryland.
  • Peer CJ; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland.
  • Figg WD; Genitourinary Malignancies Branch, Molecular Pharmacology Section, NCI, NIH, Bethesda, Maryland.
  • Gilbert MR; Genitourinary Malignancies Branch, Molecular Pharmacology Section, NCI, NIH, Bethesda, Maryland.
  • McGavern DB; Neuro-Oncology Branch, NCI, NIH, Bethesda, Maryland.
  • Muldoon LL; Viral Immunology and Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland.
  • Jackson S; Department of Neurology, Oregon Health & Sciences University, Portland, Oregon.
Mol Cancer Res ; 19(12): 2081-2095, 2021 12.
Article em En | MEDLINE | ID: mdl-34521765

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Barreira Hematoencefálica / Receptor A2A de Adenosina / Glioma Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Barreira Hematoencefálica / Receptor A2A de Adenosina / Glioma Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article